Shinoda, S., Kaino, S., Amano, S., Harima, H., Matsumoto, T., Fujisawa, K., . . . Sakaida, I. (2018). Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo. Oncotarget.
Styl ChicagoShinoda, Shuhei, et al. "Deferasirox, an Oral Iron Chelator, With Gemcitabine Synergistically Inhibits Pancreatic Cancer Cell Growth in Vitro and in Vivo." Oncotarget 2018.
Citace podle MLAShinoda, Shuhei, et al. "Deferasirox, an Oral Iron Chelator, With Gemcitabine Synergistically Inhibits Pancreatic Cancer Cell Growth in Vitro and in Vivo." Oncotarget 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..